SEFXIM-TZ 3375
SEFXIM-TZ 3375
(Ceftriaxone and Tazobactam Injection I.P.)
n
Composition:
nEach vial contains:
n
nCeftriaxone Sodium (Sterile)Â Â Â Â Â Â Â I.P.
n
nEq. to Ceftriaxone                                    3000 mg
n
nTazobactam Sodium (Sterile)Â Â Â Â Â Â Â I.P.
n
nEq. to Tazobactam                                    375 mg
n
Packaging:
n20 ml Vial + 20 ml WFI
Product Description
SEFXIM-TZ 3375 is a broad-spectrum veterinary injectable antibiotic formulation containing Ceftriaxone Sodium and Tazobactam Sodium, designed for effective management of moderate to severe bacterial infections in animals. Ceftriaxone, a third-generation cephalosporin, acts by inhibiting bacterial cell wall synthesis leading to rapid bacterial death, while Tazobactam functions as a β-lactamase inhibitor that protects ceftriaxone from enzymatic degradation, thereby enhancing antibacterial efficacy against resistant pathogens. The synergistic dual action ensures extended spectrum coverage against Gram-positive and Gram-negative bacteria.
n
nSEFXIM-TZ 3375 provides rapid systemic action, making it suitable for treating respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other bacterial infections. The formulation supports faster clinical recovery, improves treatment outcomes, and helps enhance the overall health and animals.
n
Indications:
n
-
n
- Respiratory tract infections (pneumonia, bronchitis)
- Urinary tract infections
- Skin and soft tissue infections
- Gastrointestinal bacterial infections
- Mastitis in dairy animals
- Metritis and other reproductive tract infections
- Bone and joint infections (osteomyelitis, septic arthritis)
- Septicemia and systemic bacterial infections
- Post-operative and wound infections
- Foot rot and other bacterial inflammatory conditions
n
n
n
n
n
n
n
n
n
n
n
Therapeutic Segment Positioning:
nAntibiotic (Veterinary)
